Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions (NYSE: EBS) has announced its participation in multiple upcoming investor conferences in May and June 2025. The company's executive management team will attend:
- RBC Global Healthcare Conference in New York (May 20) featuring a fireside chat at 3:35 pm ET
- Goldman Sachs Leveraged Finance Conference in Dana Point, California (May 29)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (May 29)
- Jefferies Global Healthcare Conference in New York (June 5) with a presentation at 1:25 pm ET
Virtual attendance options are available for select events, and presentation replays will be accessible through Emergent's website investor page.
Emergent BioSolutions (NYSE: EBS) ha annunciato la sua partecipazione a diverse conferenze per investitori previste per maggio e giugno 2025. Il team di gestione esecutiva dell'azienda sarà presente a:
- RBC Global Healthcare Conference a New York (20 maggio) con una conversazione informale alle 15:35 ET
- Goldman Sachs Leveraged Finance Conference a Dana Point, California (29 maggio)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 maggio)
- Jefferies Global Healthcare Conference a New York (5 giugno) con una presentazione alle 13:25 ET
Per alcuni eventi è disponibile la partecipazione virtuale, e le registrazioni delle presentazioni saranno accessibili tramite la pagina investitori del sito web di Emergent.
Emergent BioSolutions (NYSE: EBS) ha anunciado su participación en varias conferencias para inversores que se celebrarán en mayo y junio de 2025. El equipo ejecutivo de la compañía asistirá a:
- RBC Global Healthcare Conference en Nueva York (20 de mayo) con una charla informal a las 3:35 pm ET
- Goldman Sachs Leveraged Finance Conference en Dana Point, California (29 de mayo)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 de mayo)
- Jefferies Global Healthcare Conference en Nueva York (5 de junio) con una presentación a la 1:25 pm ET
Habrá opciones de asistencia virtual para algunos eventos, y las repeticiones de las presentaciones estarán disponibles en la página de inversores del sitio web de Emergent.
Emergent BioSolutions (NYSE: EBS)는 2025년 5월과 6월에 예정된 여러 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사의 경영진은 다음 행사에 참석할 예정입니다:
- RBC 글로벌 헬스케어 컨퍼런스 뉴욕 (5월 20일) 오후 3시 35분 ET에 파이어사이드 채팅
- 골드만 삭스 레버리지드 파이낸스 컨퍼런스 캘리포니아 다나포인트 (5월 29일)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (5월 29일)
- 제퍼리스 글로벌 헬스케어 컨퍼런스 뉴욕 (6월 5일) 오후 1시 25분 ET에 발표
일부 행사에는 가상 참석 옵션이 제공되며, 발표 녹화는 Emergent 웹사이트 투자자 페이지에서 시청할 수 있습니다.
Emergent BioSolutions (NYSE : EBS) a annoncé sa participation à plusieurs conférences pour investisseurs prévues en mai et juin 2025. L'équipe de direction de la société assistera à :
- RBC Global Healthcare Conference à New York (20 mai) avec une discussion informelle à 15h35 ET
- Goldman Sachs Leveraged Finance Conference à Dana Point, Californie (29 mai)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 mai)
- Jefferies Global Healthcare Conference à New York (5 juin) avec une présentation à 13h25 ET
Des options de participation virtuelle sont disponibles pour certains événements, et les rediffusions des présentations seront accessibles via la page investisseurs du site web d’Emergent.
Emergent BioSolutions (NYSE: EBS) hat seine Teilnahme an mehreren bevorstehenden Investorenkonferenzen im Mai und Juni 2025 angekündigt. Das Führungsteam des Unternehmens wird an folgenden Veranstaltungen teilnehmen:
- RBC Global Healthcare Conference in New York (20. Mai) mit einem Fireside-Chat um 15:35 Uhr ET
- Goldman Sachs Leveraged Finance Conference in Dana Point, Kalifornien (29. Mai)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29. Mai)
- Jefferies Global Healthcare Conference in New York (5. Juni) mit einer Präsentation um 13:25 Uhr ET
Für ausgewählte Veranstaltungen stehen virtuelle Teilnahmeoptionen zur Verfügung, und Präsentationsaufzeichnungen werden auf der Investorenseite der Emergent-Website zugänglich sein.
- None.
- None.
GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences:
- RBC Global Healthcare Conference (New York, New York)
Fireside chat on Tuesday, May 20 at 3:35 pm ET
Virtual attendees can participate via webcast
- Goldman Sachs Leveraged Finance Conference, May 29, 2025 (Dana Point, California)
- Benchmark’s 5th Annual Healthcare House Call Virtual Investor Conference
Presentation on Thursday, May 29
- Jefferies Global Healthcare Conference (New York, New York)
Presentation on Thursday, June 5 at 1:25 pm ET
Virtual attendees can participate via webcast
A replay of the presentations can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
Which investor conferences will Emergent BioSolutions (EBS) attend in May-June 2025?
When is Emergent BioSolutions' (EBS) presentation at the RBC Global Healthcare Conference 2025?
How can investors access Emergent BioSolutions' (EBS) conference presentations?
What time is Emergent BioSolutions' (EBS) presentation at the Jefferies Global Healthcare Conference 2025?
